Related Experiment Video
Updated: Feb 24, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.4K
Exploring the challenges for clinical pharmacists in Sudan
Hwaida Elsadig1, Marjorie Weiss2, Jenny Scott3
1University of Bath, Bath, UK. hwaida.elsadig@bath.edu.
International Journal of Clinical Pharmacy
|August 21, 2017
Summary
Sudan's clinical pharmacists are embracing new ward-based roles, focusing on drug-related problems and patient education. However, challenges like inadequate training and lack of leadership hinder progress in this evolving field.
Area of Science:
- Pharmaceutical Practice
- Health Services Research
Background:
- Clinical pharmacy practice represents a novel role for pharmacists in Sudan.
- This shift requires pharmacists to transition from traditional pharmacy settings to direct patient care on hospital wards.
- The evolving role necessitates collaboration with other healthcare professionals.
Purpose of the Study:
- To investigate the current roles of clinical pharmacists in Sudan.
- To identify the challenges encountered by clinical pharmacists in their practice.
- To understand the barriers to the advancement of clinical pharmacy services in Sudanese hospitals.
Main Methods:
- A two-phase mixed-methods approach was employed.
- Phase one involved focus group discussions with clinical pharmacists in two major government hospitals.
- Phase two consisted of an online survey distributed to clinical pharmacists across Sudan.
Main Results:
- Key perceived roles included identifying drug-related problems (100%), providing drug information (96%), and patient medication education (96%).
- Significant challenges were identified, including self-related issues, a lack of senior clinical pharmacist leadership, environmental factors, and insufficient training.
- Participant engagement: 4 in focus groups, 51 out of 140 (34%) completed the online survey.
Conclusions:
- Clinical pharmacists in Sudan face substantial challenges in establishing and advancing their practice.
- Overcoming these obstacles requires comprehensive support from pharmacy educational bodies, healthcare institutions, and interprofessional collaboration.
- Strategic interventions are needed to foster the growth of clinical pharmacy services in Sudan.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
329
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
01:26Pharmaceutical Poisoning: Potential Scenarios
37
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
37
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
359
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
01:19Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
39
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
39
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
38
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
38